A clinical review of bleomycin--a new antineoplastic agent.
D000230:Adenocarcinoma / Q000188:drug therapy; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects; D001859:Bone Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D005334:Fever / Q000139:chemically induced; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008171:Lung Diseases / Q000139:chemically induced; D008223:Lymphoma / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D012867:Skin / Q000187:drug effects; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D014565:Urogenital Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin